期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
早期气虚证H_(22)荷瘤小鼠肿瘤组织基因的表达特征
1
作者 卓少元 方肇勤 +4 位作者 卢文丽 潘志强 梁超 刘小美 高必峰 《陕西中医》 2009年第8期1086-1089,共4页
目的:揭示H22荷瘤小鼠早期气虚证肿瘤组织基因表达的特征。方法:利用实验中获得的外显子芯片数据分析H22荷瘤小鼠早期气虚证与邪毒壅盛、中期阳气虚及中晚期气阴阳虚证等3个证候肿瘤组织基因表达的差异。结果:与其它三种证候相比,在早... 目的:揭示H22荷瘤小鼠早期气虚证肿瘤组织基因表达的特征。方法:利用实验中获得的外显子芯片数据分析H22荷瘤小鼠早期气虚证与邪毒壅盛、中期阳气虚及中晚期气阴阳虚证等3个证候肿瘤组织基因表达的差异。结果:与其它三种证候相比,在早期气虚证小鼠肿瘤组织中,1上调表达的基因有8个,其中包括H2-Eb2和Sla等4个TCR或BCR有关的基因,和P2ry1、Cobra1等4个其他功能类的基因。2下调表达的基因有18个,包括MMP8/9/10等3个MMPs家族基因,S100a8、S100a9等2个S100家族基因,Lcn2、Clec4d等5个细胞因子和粘附分子类基因,以及Slc6a9、Ddit4等其他功能类的基因8个。结论:早期气虚证H22荷瘤小鼠肿瘤组织中存在大量差异性表达的基因,上调表达的数量少,下调表达的数量多,可能是该证候与其他证候区别的内在特征。 展开更多
关键词 肿瘤/病因 基因 表达
下载PDF
浅谈任林军主任中医师治疗肿瘤的思路及学术思想
2
作者 曲保利 《中国民族民间医药》 2011年第5期10-11,共2页
任林军主任医师在学术上主张"虚、痰瘀、结"为肿瘤发生发展必然规律,善于应用辩证补虚、除痰化瘀、散结治疗肿瘤等内科杂病。今将任林军老师治疗肿瘤的思路及学术思想总结以供临床参考。
关键词 肿瘤病因病机 治疗 思路和学术思想
下载PDF
Kimchi and soybean pastes are risk factors of gastric cancer 被引量:8
3
作者 Hong-MeiNan Jin-WooPark +7 位作者 Young-JinSong Hyo-YungYun Joo-SeungPark TaisunHyun Sei-JinYoun Yong-DaeKim Jong-WonKang HeonKim 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第21期3175-3181,共7页
AIM: This case-control study investigated the effects of kimchi,soybean paste, fresh vegetables,nonfermented alliums, nonfermented seafood, nonfermented soybean foods, and the genetic polymorphisms of some metabolic e... AIM: This case-control study investigated the effects of kimchi,soybean paste, fresh vegetables,nonfermented alliums, nonfermented seafood, nonfermented soybean foods, and the genetic polymorphisms of some metabolic enzymes on the risk of gastric cancer in Koreans. METHODS: We studied 421 gastric cancer patients and 632 age- and sex-matched controls. Subjects completed a structured questionnaire regarding their food intake pattern. Polymorphisms of cytochrome P450 1A1 (CYP1A1), cytochrome P450 2E1 (CYP2E1), glutathione S-transferase mu 1 (GSTM1),glutathione S-transferase theta 1 (65777) and aldehyde dehydrogenase 2 (ALDH2) were investigated. RESULTS: A decreased risk of gastric cancer was noted among people with high consumption of nonfermented alliums and nonfermented seafood. On the other hand, consumption of kimchi, and soybean pastes was associated with increased risk of gastric cancer. Individuals with the CYP1A1 Ile/Val or Val/Val genotype showed a significantly increased risk for gastric cancer. Increased intake of kimchi or soybean pastes was a significant risk factor for the CYP1A1 lie/lie, the CYP2E1 c1/c1,the GSTM1 non-null, the GSTT1 non-null, or the ALDH2 *1/*1 genotype.In addition, eating soybean pastes was associated with the increased risk of gastric cancer in individuals with the GSTM1 null type. Nonfermented alliums were significant in individuals with the CYP1A1 lie/lie, the CYP2E1 c1/c2 or c2/c2, the GSTT1 null, the GSTT1 non-null, or the ALDH2 *1/*2 or *2/*2 genotype,nonfermented seafood was those with the CYP1A1 lie/lie,the CYP2E1 c1/c1, the ALDH2 *1/*1 genotype or any type of GSTM1 or GSTT1. In homogeneity tests, the odds ratios of eating kimchi for gastric cancer according to the GSTM1 or 65777 genotype were not homogeneous. CONCLUSION: Kimchi, soybean pastes, and the CYP1A1 Ile/Val or Val/Val are risk factors,and nonfermented seafood and alliums are protective factors against gastric cancer in Koreans. Salt or some chemicals contained in kimchi and soybean pastes, which are increased by fermentation,would play important roles in the carcinogenesis of stomach cancer.Polymorphisms of the CYP1A1, CYP2E1, GSTM1, GSTT1, and ALDH2 genes could modify the effects of some environmental factors on the risk of gastric cancer. 展开更多
关键词 KIMCHI Soybean pastes Gastric cancer
下载PDF
Gastric sarcoidosis mimicking irritable bowel syndrome-Cause not association? 被引量:3
4
作者 John Samuel Leeds Mark Edward McAlindon +2 位作者 Eleanor Lorenz Asha Kumari Dube David Surendran Sanders 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第29期4754-4756,共3页
Sarcoidosis is a systemic disease of unknown aetiology that may affect any organ in the body. The gastrointestinal tract however is only rarely affected outside the liver. Symptoms may be non-specific. Irritable b... Sarcoidosis is a systemic disease of unknown aetiology that may affect any organ in the body. The gastrointestinal tract however is only rarely affected outside the liver. Symptoms may be non-specific. Irritable bowel syndrome (IBS) is a common diagnosis. The recognition of IBS is aided by the use of the Rome Ⅱ criteria-in the absence of organic disease. We describe the first case of a patient with gastric sarcoidosis who presented with IBS symptoms but subsequently responded to immunosuppressive therapy. 展开更多
关键词 GASTROINTESTINAL SARCOIDOSIS Irritable bowelsyndrome
下载PDF
Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand 被引量:17
5
作者 Pisit Tangkijvanich Varocha Mahachai +3 位作者 Piyawat Komolmit Juthatip Fongsarun Apiradee Theamboonlers Yong Poovorawan 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第15期2238-2243,共6页
AIM: The role of hepatitis B virus (HBV) genotypes on the clinical features and prognosis of patients with hepatocellular carcinoma (HCC) is currently unknown. The aim of the present study was to evaluate the distribu... AIM: The role of hepatitis B virus (HBV) genotypes on the clinical features and prognosis of patients with hepatocellular carcinoma (HCC) is currently unknown. The aim of the present study was to evaluate the distribution of HBV genotypes and their clinical relevance in Thai patients.METHODS: HBV genotypes were determined by PCR-RFLP in stored sera of 93 asymptomatic carriers, 103 patients with chronic hepatitis, 60 patients with cirrhosis and 76patients with HCC. The clinical data were analyzed in relation to the HBV genotype.RESULTS: HBV genotypes C and B were predominant in Thailand, accounting for 73% and 21%, respectively. The distributions of genotypes B and C were similar in HCC patients compared to the other groups. Genotype C was significantly more common in HCC patients who were under 40 years old than genotype B (18% vs 0%, P= 0.03), but was significantly less common in patients older than 60 years (26% vs 56.5%, P= 0.01). The positive rate of hepatitis B e antigen (HBeAg) in patients with genotype C was significantly higher than that in patients with genotype B (71.6% vs 44.4%, P = 0.03 in chronic hepatitis; 56.8% vs 11.1%,P = 0.01 in cirrhosis). There were no differences between HCC patients with genotypes B and C regarding tumor staging by CLIP criteria and the overall median survival. Multivariate analyses showed that HBV genotype was not an independent prognostic factor of survival in HCC patients.CONCLUSION: Patients with genotype C had a higher positive rate of HBeAg and exhibited earlier progression of cirrhosis and HCC than those with genotype B. However,there were no differences in the risk of developing HCC and its prognosis between patients with these genotypes. 展开更多
关键词 HBV GENOTYPE Hepatocellular carcinoma
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部